Abstract
Pharmaceutical industry is one of the most risky and intensive business in terms of safety and risk assessment. Pharmaceutical company faces many challenges at various stages such as pre-clinical, clinical trial and post-marketing. The paper attempts to provide the best method for assessing the level of risk for pharmaceutical companies. It evaluates a construction management risk assessment which comprises an integrated approach that aims to carry out a process with best scientific methods to identify, analyze and mitigate risks during different phases of industry from pre-conceptual design to clinical research.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
